SARS-CoV-2 compromises blastocyst quality by modifying the ovarian microenvironment.

Publication date: Feb 18, 2025

Open Access PDF

Concepts Keywords
Blastocyst Blastocyst
Microenvironment Compromises
Ovarian Cov
Signal Microenvironment
Target Modifying
Ovarian
Sars
Signal
Target
Ther
Transduct

Semantics

Type Source Name
disease IDO quality
pathway REACTOME Signal Transduction
disease MESH COVID 19 pandemic
disease IDO cell
drug DRUGBANK Natural alpha interferon
disease MESH infection
disease MESH papillomavirus infection
disease MESH Hepatitis
disease MESH Influenza
drug DRUGBANK Amino acids
drug DRUGBANK Piperazine
drug DRUGBANK Ethanesulfonic Acid
drug DRUGBANK Glycerin
pathway REACTOME Metabolism
pathway KEGG ABC transporters
pathway REACTOME Fertilization
pathway REACTOME Sphingolipid metabolism
pathway KEGG Pyrimidine metabolism
pathway KEGG Glycerophospholipid metabolism
drug DRUGBANK Glycine
drug DRUGBANK Serine
pathway KEGG Ether lipid metabolism
disease MESH tryptophan
drug DRUGBANK L-Tryptophan
drug DRUGBANK Coenzyme M
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)